Pharma clinics. Comment je traite ... un herpes labial récurrent.

Acyclovir/therapeutic use; Antiviral Agents/therapeutic use; Herpes Labialis/drug therapy/pathology; Humans; Hydrogen-Ion Concentration; Lipoproteins/therapeutic use; Recurrence; Skin Physiological Phenomena

Abstract :

[en] Recurrent herpes labialis is a frequent disorder. It occurs following the reactivation of the Herpesvirus (HSV1 and more rarely HSV2) inside the Gasser ganglion. Treatment and prevention of recurrent labial herpes are targeted by specific antiviral agents. Spectacular benefits obtained in the immunocompromised patients are less convincing in otherwise healthy subjects. Other prospective ways of therapy are under consideration, including lipopeptides and physical means aiming at modifying the cutaneous pH.

Disciplines :

Dermatology

Author, co-author :

Petit, L.; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Braham, C.; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Nikkels, Arjen ; Centre Hospitalier Universitaire de Liège - CHU > Dermatologie

Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

French

Title :

Pharma clinics. Comment je traite ... un herpes labial récurrent.

Alternative titles :

[en] Pharma clinics. How I treat ... recurrent herpes labialis.

Publication date :

2002

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

67-71

Peer reviewed :

Peer reviewed

Available on ORBi :

since 20 April 2009

Statistics

Number of views

479 (4 by ULiège)

Number of downloads

1137 (5 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Jarrat M. (1983) Herpes simplex infection. Arch Dermatol 119:99-103.
Pereira F.A. (1996) Herpes simplex, evolving concepts. J Am Acad Dermatol 35:503-520.
Nikkels A.F., Delvenne P., Sadzot-Delvaux C. (1996) Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol 49:243-248.
Aghazarian S., Nikkels A.F., Grodos J. (1997) Occult genital herpes presenting as an endometrial infection detected at delivery. A report of two cases. J Eur Acad Dermatol Vener 9:276-282.
Nikkels A.F., Piérard G.E. (2000) Approche factuelle du traitement de l'herpès génital. Rev Med Liège 55:430-437.
Halford W.P., Gebhardt B.M., Carr D.J. (1996) Mechanisms of herpes simplex virus type I reactivation. J Virol 70:5051-5060.
Young T.B., Rimm E.B., D'Alessio D.J. (1988) Cross-sectional study of recurrent herpes labialis. Prevalence and risk factors. Am J Epidemiol 127:612-625.
Gibson J.J., Hornung C.A., Alexander G.R. (1990) A cross-sectional study of herpes simplex virus type 1 and 2 in college students, occurrence and determinants of infection. J Infect Dis 162:306-312.
Simmons A. (1997) An open-label study conducted to evaluate the efficacy of Betadine cold sore paint. Dermatology 195(SUPPL. 2):85-88.
Nikkels A.F., Piérard G.E. Treatment of muco-cutaneous presentations of herpes simplex virus infections. Am J Clin Dermatol, sous presse; .
Gonik B., Loo L.S., Bigelow R. (1985) Influence of menstrual cycle variations on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to cells infected with herpes simplex virus. J Reprod Med 30:493-496.
Perna J.J., Mannix M.L., Rooney J.F. (1987) Reactivation of latent herpes simplex virus infection by ultraviolet light, a human model. J Am Acad Dermatol 17:473-478.
Schmidt D.D., Schmidt P.M., Crabtree B.F. (1991) The temporal relationship of psychosocial stress to cellular immunity and herpes labialis recurrences. Fam Med 23:594-599.
Dalkvist J., Wahlin T.B., Barstch E. (1995) Herpes simplex and mood, a prospective study. Psychosom Med 57:127-137.
Padgett D.A., Sheridan J.F., Dorne J. (1998) Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci USA 95:7231-7235.
Scott D.A., Coulter W.A., Lamey P.J. (1997) Oral shedding of herpes simplex virus type 1, a review. J Oral Pathol Med 26:441-447.
Lekstrom-Himes J.A., Pesnicak L., Straus S.E. (1998) The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks. J Virol 72:2760-2764.
Sawtell N.M. (1998) The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J Virol 72:6888-6892.
Hamdi D., Arrese Estrada J., Cornil F. (1992) L'érythème polymorphe et sa relation avec l'herpès simplex I et II. Rev Med Liège 47:70-74.
Nikkels A.F., Hermanns-Le T., Nikkels-Tassoudji N. (1993) Diagnostic des infections cutanées par les herpes virus de types simplex et varicelle-zona. Rev Med Liège 48:401-405.
Nikkels A.F., Debrus S., Sadzot-Delvaux C. (1993) Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Archiv A 422:121-126.
Nikkels A.F., Debrus S., Delvenne P. (1994) Viral glycoproteins in Herpesviridae granulomas. Am J Dermatopathol 16:588-592.
Nikkels A.F., Sadzot-Delvaux C., Rentier B. (1998) Low-productive alpha-Herpesviridae infection in chronic lichenoid dermatoses. Dermatology 196:442-446.
Nikkels A.F., Piérard G.E. (1999) Chronic herpes simplex virus type I glossitis in an immunocompromised man. Br J Dermatol 140:343-346.
Nikkels A.F., Frere P., Rakic L. (1999) Simultaneous reactivation of herpes simplex virus and varicella zoster virus in a patient with idiopathic thrombocytopenic purpura. Dermatology 199:361-364.
Nikkels A.F., Piérard G.E. (2002) Current treatments of mucocutaneous herpes simplex virus infections. Current Med Chem Anti Infect Ag 1:83-98.
Amir J., Harel L., Smetana Z. (1997) Treatment of herpes simplex gingivostomatitis with aciclovir in children, a randomised double blind placebo controlled study. BMJ 314:1800-1803.
Rooney J.F., Bryson Y., Mannix M.L. (1991) Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet 338:1419-1422.
Spruance S.L., Hamill M.L., Hoge W.S. (1988) Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA 260:1597-1599.
Spruance S.L. (1993) Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis. J Med Virol Suppl 1:27-32.
Razafindralambo H., Popineau Y., Deleu M. (1997) Surface-active properties of surfactin/iturin mixtures produced by Bacillus subtilis. Langmuir 13:6026-6031.